<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>680</id><JournalTitle>EFFECT OF COMBINATION OF SUBEROYLANILIDE  HYDROXAMIC ACID AND O2Ê¹, O3Ê¹, O5Ê¹-TRI-ACETYL-N6-(3-HYDROXYLANILINE) ADENOSINE ON VARIOUS OBESITY  RELATED MARKERS IN 3T3-L1 PRE-ADIPOCYTIC CELL LINE</JournalTitle><Abstract>Combinational  therapies  are  among  the  attractive  treatment  strategies  for  the  pathological  states  where  multiple 
regulatory mechanisms contribute to the development and the progression of the disease. In our present study, we investigated
the  effects  of  combination  of  Suberoylanilide  hydroxamic  acid  [SAHA]  and  O2',  O3',  O5' -tri-acetyl-N6-(3-hydroxylaniline) 
adenosine [THA] on viability, adipogenesis and apoptosis in 3T3-L1 pre-adipocytic cell line. Mature adipocytes when treated 
individually with either SAHA or THA decreased cell viability but the combination of SAHA and THA  caused an enhanced 
decrease  in  cell  viability.  The  combination  of  drugs  also  showed  an  enhanced  inhibition  of  adipocyte  differentiation  as 
monitored  by  Oil  Red  O  Staining.  The  western  blot  analysis  revealed  that  SAHA  and  THA  when  used  in  combination 
decreased the expression levels of peroxisome  proliferator-activated receptor gamma  (PPAR-Î³) and  CCAAT/enhancer binding 
protein (C/EBPÎ±), both of which act as key regulators of adipogenesis. Furthermore, the combination of drugs increased the 
expression levels of Bcl-2 associated X protein (Bax) which is a pro-apoptotic protein involved in mediating apoptosis. Thus, 
the combination of SAHA and THA seem to exert multi -potent anti-obesity effects and seem to have promising benefits for the 
treatment and prevention of obesity</Abstract><Email>haq@kashmiruniversity.net</Email><articletype>Research</articletype><volume>6</volume><issue>10</issue><year>2015</year><keyword>Adipocyte differentiation,apoptosis,peroxisome proliferator-activated receptor gamma,CCAAT/enhancer binding  protein,Obesity.</keyword><AUTHORS>Taseen Gul,Henah M. Balkhi,G. Lakshma Reddy,Sanghapal D. Sawant, Abid Hamid,Ehtishamul Haq</AUTHORS><afflication>Department of Biotechnology, University of Kashmir, Hazratbal, Srinagar J&K, India.,Department of Biotechnology, University of Kashmir, Hazratbal, Srinagar J&K, India.,Medicinal Chemistry Division, Indian Institute of Integrative Medicine, Jammu, J&K, India,Medicinal Chemistry Division, Indian Institute of Integrative Medicine, Jammu, J&K, India,Medicinal Chemistry Division, Indian Institute of Integrative Medicine, Jammu, J&K, India,Department of Biotechnology, University of Kashmir, Hazratbal, Srinagar J&K, India.</afflication></Article></Articles>